Sclerotherapy is a minimally invasive procedure performed by a healthcare provider to treat uncomplicated spider veins and uncomplicated reticular veins. It involves an injection of a solution (sclerosis agent) into the affected veins. It has been used since 1939.

A typical sclerotherapy session lasts 15 to 45 minutes. More than one treatment may be necessary to clinically treat superficial veins 3mm or less in diameter. 2-3 treatments separated 4-6 weeks are usually needed for desired results. 

Sclerotherapy is contraindicated on patients who have the following:

  • Known Allergy (anaphylaxis) to polidocanol and patients with acute thromboembolic disease

  • Pregnancy/lactating 

  • Acute illness 

  • Diabetic*

  • Corticosteroid use 

  • Severe circulatory problems such as cellulitis 

  • Debilitated individuals 

  • Autoimmune disorders 

  • Anticoagulant therapy